Visalytics
Visalytics
approved EB-2 (NIW)

Research Associate

Biotechnologies · Pakistan · 2023-02-14

Processing Time
41 days
Decision Date
2023-02-14
Location
Illinois
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research on identifying novel therapeutic drug targets in aggressive triple-negative breast cancer. Her work focuses on developing new therapies to improve existing treatment strategies, overcome chemoresistance, and minimize cancer recurrence rates for breast cancer patients.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses aggressive triple-negative breast cancer and public health challenges like asthma, which are of evident national importance.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record, and 42 citations demonstrate she is well-positioned to succeed in her field.

3 Waiver of Job Offer and Labor Certification Met

Based on the multifactorial assessment of her expertise and the impact of her work, it was found beneficial to the U.S. to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in Biomedical Sciences and her record of 4 peer-reviewed journal articles and 2 conference abstracts. Her work had garnered 42 citations at the time of filing and was supported by 4 expert recommendation letters. The case successfully satisfied all three Dhanasar prongs, demonstrating the national importance of her cancer research.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Conference Presentations
Original Contributions

Similar Cases

Doctor

Healthcare · India

WeGreened EB-2 (NIW) approved
California 84 days 2026-01-09
The petitioner proposes to continue her research in breast oncology, specifically identifying genomic markers and tumor microenvironmental determinants to manage breast cancer progression. Her work focuses on distinguishing between high-risk patients requiring immediate intervention and low-risk patients suitable for non-surgical watchful waiting. This research aims to facilitate new immune-based treatments and reduce the burden of unnecessary surgeries in the U.S. healthcare system.
View Case

Postdoctoral Researcher

Research and Development · India

WeGreened EB-2 (NIW) approved
New Jersey 173 days 2022-04-11
The petitioner proposes to systematically characterize genes and pathways involved in cancer development and progression using laboratory-based and animal models to study biological and clinical phenotypes. This work aims to identify novel molecular targets for cancer diagnosis, prognosis, and treatment modalities, specifically focusing on advanced breast cancer.
View Case

Others

Biotechnology · Hong Kong

WeGreened EB-2 (NIW) approved
Illinois 446 days 2022-08-23
The petitioner proposes to continue research on the behavior of the immune system in skin cancers and identify new mutations that drive their formation. This work aims to develop new therapies against cancer, specifically focusing on molecular mediators of breast cancer metastasis and treatments for autoimmune and inflammatory bowel diseases.
View Case

Assistant Professor

Healthcare · Pakistan

WeGreened EB-2 (NIW) approved
District of Columbia 3 days 2023-08-23
The petitioner proposes to continue her research in pathology with a focus on molecular pathology and personalized treatment strategies for breast and genitourinary cancers. Her work involves developing tissue microarray analysis techniques to extract genomic and immunohistochemical data for more accurate cancer diagnostics. She also aims to discover molecular markers for rare and treatment-resistant tumors, particularly in underserved populations.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Pakistan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-14.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 41 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Pakistan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist